INVO Fertility Reports Modest Revenue Growth Amid Continued Losses — INVO Fertility, Inc.

Event summary

INVO Fertility reported $6.8M in revenue for FY2025, a 5% increase from FY2024.
Net loss from continuing operations narrowed to $(5.3M) from $(7.7M) year-over-year.
Company raised $11.5M in financing in late 2025 and early 2026, strengthening its balance sheet.
Acquired Indiana-based Family Beginnings in February 2026, adding a fourth U.S. clinic.
Wisconsin Fertility Institute joined the Progyny network, expanding employer-benefit access.

The big picture

INVO Fertility's modest revenue growth and narrowed losses reflect a period of stabilization and strategic repositioning. The company is leveraging financing and acquisitions to strengthen its balance sheet and expand its clinic network, aligning with broader industry trends of increasing employer-benefit coverage and public awareness around fertility care access. The focus on organic growth initiatives and technological innovation positions INVO Fertility to capitalize on long-term demand trends in assisted reproductive technology.

What we're watching

Organic Growth: The pace at which INVO Fertility can drive meaningful organic growth across its existing clinics, particularly with new initiatives at its Atlanta clinic.
Acquisition Strategy: Whether INVO Fertility can sustain its disciplined acquisition approach while maintaining financial stability and operational integration.
Market Positioning: How the company's focus on the INVOcell platform and payer access expansion will affect its competitive positioning in the fertility care market.